Traws Pharma Inc.
Organization details
- Legal name
- Traws Pharma Inc.
- Former names
- Onconova Therapeutics, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Newtown
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TRAW
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001130598
Board of directors
-
Iain D. Dukes · Director · Chief Executive OfficerSince 2024
-
Jack E. Stover · DirectorSince 2023
-
James J. Marino · DirectorSince 2023
-
Jerome Groopman · DirectorSince 2023
-
John Harold Leaman · DirectorSince 2025
-
Luba Greenwood · DirectorSince 2024
-
Mary Teresa Shoemaker · DirectorSince 2023
-
Nikolay Savchuk · Director · Chief Operating OfficerSince 2024
-
Peter Atadja · DirectorSince 2023
-
Steven M. Fruchtman · Director · PRESIDENT, CHIEF EXECUTIVE OFFSince 2023
-
Trafford Clarke · DirectorSince 2023
-
Viren Mehta · DirectorSince 2023
-
Werner Cautreels · Director · Chief Executive OfficerSince 2024
Chief executives
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
251.4% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Director election results
Annual meeting of July 8, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
87.3%
-
87.5%
-
87.6%
-
98.9%
-
99.1%
Board connections
4 of this board's directors also sit on 6 other boards. 6 are in the same sector.
-
Celldex Therapeutics Inc. Same sectorvia James J. Marino
-
IN8bio Inc. Same sectorvia Luba Greenwood
-
ImageneBio Inc. Same sectorvia Iain D. Dukes
-
Iovance Biotherapeutics Inc. Same sectorvia Iain D. Dukes
-
Profusa Inc. Same sectorvia Jack E. Stover
-
TransCode Therapeutics Inc. Same sectorvia Jack E. Stover
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $998,207
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 16, 2026 | OrbiMed Capital GP VIII LLC 10% owner | Open-market purchase | +597,729 | $1.67 | $998,207 |
| Dec 12, 2025 | John Harold Leaman Director | Grant or award | +4,058 | — | — |
| Dec 12, 2025 | Trafford Clarke Director | Grant or award | +6,157 | — | — |
| Dec 12, 2025 | Werner Cautreels Director | Grant or award | +4,874 | — | — |
| Dec 12, 2025 | Mary Teresa Shoemaker Director | Grant or award | +6,157 | — | — |
| Dec 12, 2025 | Jack E. Stover Director | Grant or award | +6,157 | — | — |
| Dec 12, 2025 | Iain D. Dukes Director, Officer (Chief Executive Officer) | Grant or award | +36,943 | — | — |
| Dec 12, 2025 | Pauza Charles David Officer (Chief Science Officer Virology) | Grant or award | +18,471 | — | — |
| Dec 12, 2025 | Redfield Robert Officer (Chief Medical Officer) | Grant or award | +16,419 | — | — |
| Dec 12, 2025 | Nikolay Savchuk Director, Officer (Chief Operating Officer) | Grant or award | +16,419 | — | — |
| Dec 12, 2025 | Parker Charles Nolan Officer (Chief Financial Officer) | Grant or award | +15,393 | — | — |
| Apr 2, 2025 | Nikolay Savchuk Officer (Chief Operating Officer), 10% owner | Other | −605,531 | — | — |
| Feb 18, 2025 | Werner Cautreels Director, Officer (Chief Executive Officer) | Option exercise | +96,348 | $0.01 | $963 |
| Jun 18, 2024 | Guerin Mark Patrick Officer (CFO) | Shares withheld for tax | −2,221 | $0.47 | $1,044 |
| Jun 10, 2024 | Guerin Mark Patrick Officer (CFO) | Option exercise | +5,500 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Traws Pharma Inc.
Who is the CEO of Traws Pharma Inc.?
Werner Cautreels has been Traws Pharma Inc.'s Chief Executive Officer since April 2024.
How many directors are on Traws Pharma Inc.'s board?
Traws Pharma Inc.'s board has 13 directors: Iain D. Dukes, Jack E. Stover, James J. Marino, Jerome Groopman, John Harold Leaman, Luba Greenwood, Mary Teresa Shoemaker, Nikolay Savchuk, Peter Atadja, Steven M. Fruchtman and 3 others.
Are Traws Pharma Inc. insiders buying or selling shares?
Over the last 12 months, Traws Pharma Inc. insiders bought $998,207 of shares in 1 purchase and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="traws-pharma-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.